Description

They arise from the anti-inflammatory activity of flurbiprofen, the importance of the manifestations of intolerance to which the drug gives rise and its place in the range of currently available anti-inflammatory products. They are limited, in adults and children from 15 years of age, to: 1/ Long-term symptomatic treatment: * of chronic inflammatory rheumatism, in particular rheumatoid arthritis, ankylosing spondylitis or related syndromes, such as Fiessinger-Leroy-Reiter syndrome and psoriatic rheumatism, * of certain painful and disabling osteoarthritis. 2/ Short-term symptomatic treatment of acute attacks of: abarticular rheumatism such as scapulohumeral periarthritis, tendonitis, bursitis, osteoarthritis, lower back pain, radiculalgia. 3/ Dysmenorrhea after etiological investigation.